Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Christopher Horan

Chief Tech Operations Officer at Artiva Biotherapeutics, Inc. (ARTV)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $249K

Reported trades

Filed Stock Type Shares Price Value Since
Oct 6SEC ARTVArtiva Biotherapeutics, Inc. Sell 10,340312,744 held (−3%) $6.84 $71K -14.4%
Sep 4SEC ARTVArtiva Biotherapeutics, Inc. Sell 10,366283,084 held (−4%) $11.16 $116K -47.6%
May 19SEC ARTVArtiva Biotherapeutics, Inc. Sell 7,002293,450 held (−2%) $9.01 $63K -35.1%